Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Stereotaxis Inc. (STXS) vs Utah Medical Products, Inc. (UTMD)

Stereotaxis Inc. and Utah Medical Products, Inc. are both Medical Instruments & Supplies companies. Utah Medical Products, Inc. is the larger, with a market value of $238.0M against $133.3M — 1.8× the size. Stereotaxis Inc. has negative trailing earnings, so its P/E is not meaningful; Utah Medical Products, Inc. trades at 22.7×. Stereotaxis Inc. grew revenue faster over the last twelve months: −5.46% against −7.00%. Utah Medical Products, Inc. has the higher net margin (29.0% vs −78.5%) and the higher return on invested capital (18.6% vs −203.6%). Across the 18 metrics below, Utah Medical Products, Inc. leads on 13 and Stereotaxis Inc. on 5.

Valuation

Metric STXS UTMD Medical Instruments & Supplies median
P/E n/m 22.69 34.17
P/S 4.32 6.56 2.83
P/B 10.62 1.94 2.82
Price to free cash flow n/m 20.70 25.69
EV/EBITDA n/m 11.82 16.08
EV/Sales 4.16 4.17 3.06
Earnings yield (18.46%) 4.41% (1.84%)
Free cash flow yield (11.92%) 4.83% 0.17%

Profitability

Metric STXS UTMD Medical Instruments & Supplies median
Gross margin 55.57% 57.90% 54.62%
Operating margin (75.68%) 28.43% 1.64%
Net margin (78.45%) 29.04% 0.00%
Free cash flow margin (51.56%) 31.70% 1.61%
Return on equity (344.36%) 8.75% 0.00%
Return on assets (48.76%) 8.55% 0.00%
Return on invested capital (203.58%) 18.60% 0.00%

Growth

Metric STXS UTMD Medical Instruments & Supplies median
Revenue growth (TTM) (5.46%) (7.00%) 9.20%
EPS growth (last fiscal year) 16.67% (12.12%) —
Revenue growth, 5-year CAGR 3.99% (1.80%) 9.48%
Net income growth, 5-year CAGR 0.00% 0.89% 0.00%

Health

Metric STXS UTMD Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.08
Current ratio 1.42 48.62 2.49
Net debt to EBITDA 0.65 (5.95) 0.83

Dividend

Metric STXS UTMD Medical Instruments & Supplies median
Dividend yield — 1.60% 0.99%
Payout ratio 0.00 0.25 0.00

Size

Metric STXS UTMD Medical Instruments & Supplies median
Market cap 133.27m 237.99m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack